Results 181 to 190 of about 742,756 (306)
Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer Data
ABSTRACT Objective Therapeutic development for mitochondrial diseases, rare genetic disorders with pathogenic defects of oxidative phosphorylation, is hindered by unsatisfactory outcome measures. To address this problem, we provide the first clinical application of a novel, bias‐adjusted outcome measure of acceleration across a range of subjects ...
Ian W. McKeague +8 more
wiley +1 more source
HilE mediates motility thermoregulation in typhoidal Salmonella serovars at elevated physiological temperatures. [PDF]
Shem-Tov R, Gal-Mor O.
europepmc +1 more source
Effect of the MACS technique on rabbit sperm motility [PDF]
Jaromír Vašíček +2 more
openalex +1 more source
Characteristics of Cerebral Palsy in the Midwestern US
ABSTRACT Objective Cerebral palsy (CP) is the most common lifelong motor disability worldwide. Yet, data is limited on how CP manifests in the US. Our objective was to characterize and determine factors affecting functional outcomes in a large population of young people with CP in the Midwestern US.
Susie Kim +6 more
wiley +1 more source
Determination of spermatological characteristics of Carrier pigeons (<i>Columba livia domestica</i>) raised by local breeders. [PDF]
Acısu TC +11 more
europepmc +1 more source
Inhibition of Cell Motility by Fucoidan Derived from Cladosiphon Okamuranus
Yumi Yamasaki +4 more
openalex +2 more sources
CSF Mitochondrial DNA: Biomarker of Body Composition and Energy Metabolism in Parkinson's Disease
ABSTRACT Objective Cerebrospinal fluid (CSF) cell‐free mitochondrial DNA (cf‐mtDNA) is a potential biomarker for Parkinson's disease (PD), but its clinical relevance remains unclear. We investigated associations between CSF cf‐mtDNA levels, body composition, nutritional status, and metabolic biomarkers in PD. Methods CSF cf‐mtDNA levels, defined as the
Yasuaki Mizutani +11 more
wiley +1 more source

